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ABSTRACT
Context: This study was part of the Methods of
Assessing Response to Quality Improvement Strategies
(MARQuIS) research project investigating the impact of
quality improvement strategies on hospital care in various
countries of the European Union (EU), in relation to
specific needs of cross-border patients.
Aim: This paper describes how EU hospitals have applied
seven quality improvement strategies previously defined
by the MARQuIS study: organisational quality manage-
ment programmes; systems for obtaining patients’ views;
patient safety systems; audit and internal assessment of
clinical standards; clinical and practice guidelines;
performance indicators; and external assessment.
Methods: A web-based questionnaire was used to
survey acute care hospitals in eight EU countries. The
reported findings were later validated via on-site survey
and site visits in a sample of the participating hospitals.
Data collection took place from April to August 2006.
Results: 389 hospitals participated in the survey;
response rates varied per country. All seven quality
improvement strategies were widely used in European
countries. Activities related to external assessment were
the most broadly applied across Europe, and activities
related to patient involvement were the least widely
implemented. No one country implemented all quality
strategies at all hospitals. There were no differences
between participating hospitals in western and eastern
European countries regarding the application of quality
improvement strategies.
Conclusions: Implementation varied per country and per
quality improvement strategy, leaving considerable scope
for progress in quality improvements. The results may
contribute to benchmarking activities in European
countries, and point to further areas of research to explore
the relationship between the application of quality
improvement strategies and actual hospital performance.
Quality and safety of patient care are high on the
European policy agenda, as evidenced by various
commitments by European health ministries.
Patient mobility has clearly been a triggering
factor. Governments may fear that differences in
the perceived quality or costs of health services
may encourage patients to cross borders to obtain
healthcare.
1–3 The fact that member states are now
talking about what is still their responsibility has
increased the need for information about the cross-
border movement. The Methods of Assessing
Response to Quality Improvement Strategies
(MARQuIS) research project aims to be instru-
mental in providing a better understanding of this
movement, by investigating and comparing differ-
ent quality improvement (QI) strategies in health-
care systems across the European Union.
In this article we focus on the degree to which
QI strategies are applied at European hospitals, by
their own report. As presented in the Health Care
Quality Strategies in Europe study, we identified
seven national QI strategies.
45Our primary focus
is on implementation of the strategies at the EU
level; data at the country level are reported for
reference purposes. The QI strategies we investi-
gated were:
c organisational quality management pro-
grammes;
c systems for obtaining patients’ views;
c patient safety systems;
c audit and internal assessment of clinical stan-
dards;
c clinical and practice guidelines;
c performance indicators and measurements;
c external assessment.
The countries participating in this study were
Spain, France, Poland, Czech Republic, the UK,
Ireland, Belgium and the Netherlands.
MATERIAL AND METHODS
Questionnaire design
We conducted a web-based questionnaire survey.
The questionnaire was developed to measure QI,
defined as the application of quality policies and
procedures, quality governance structures, and
quality activities used to close the gap between
current and expected levels of quality.
4 To deter-
mine the distinctive aspects of QI we used several
sources, such as existing QI questionnaires,
6–9 a
review of the quality literature,
10–12 an analysis of
accreditation manuals,
11 13 14 and the results of
previous MARQuIS studies including a literature
review covering QI strategies in member states of
the EU, and an analytical framework defining areas
of QI policies and strategies. A glossary of quality
concepts and tools was made available to partici-
pants.
The questionnaire consisted of four sections: one
section focused on QI at the hospital level, the
other three on quality management for specific
medical conditions. The three medical conditions
for focused data collection were selected based on
two criteria: the condition had to represent a
significant volume of cross-border patient care,
15
and the combination of conditions was intended to
cover the most relevant services offered by a
hospital—that is, emergency surgical and medical
services, and maternal and neonatal services. The
three conditions selected were acute myocardial
infarctions (AMI), acute appendicitis and deliv-
eries. For each condition selected, the literature was
searched for specific QI strategies. Search terms
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‘‘quality assessment’’, and ‘‘performance measurement’’.
16–31 We
stopped searching when additional publications no longer
resulted in new relevant QI strategies, activities or measures.
Practising medical specialists were consulted for their comments
and suggestions on the specific QI strategies, activities, and
measures (see Acknowledgements).
Both members of the MARQuIS team and the nine country
coordinators reviewed the draft questionnaire. (For Belgium two
country coordinators were appointed, one for Flemish-speaking
and one for French-speaking hospitals.) The questionnaire was
then pilot tested in two hospitals in Ireland and the UK (these
countries were chosen for language-related reasons), and a few
amendments were made as a result. The questionnaire was
translated into five languages (Spanish, French, Polish, Czech,
and Dutch); the country coordinators were responsible for
translation. A forward–backward translation protocol was used.
Figure 1 shows the final structure of the questionnaire, which
totalled 199 questions. For each of the four sections a preferred
respondent (at the senior level) was suggested.
Response categories
Various scoring scales were used depending on the type of
question. Items were scored on a two-point scale (yes/no), a
four-point scale (see tables 2 to 8 in Results), or a five-point
Likert scale (1= strongly agree, 5= strongly disagree).
Sampling and recruitment
Our survey focused on European hospitals with a minimum of
100 acute care beds, and offering care for at least two out of the
three conditions selected for study (AMI, appendicitis and
deliveries). Two additional criteria defined the hospital sample:
ownership status (public, private not-for-profit and private for-
profit), and actual or potential cross-border care delivery.
31 The
target was to include a total of 600 hospitals covering eight
countries. For smaller countries (Belgium, the Netherlands,
Ireland, Czech Republic) this meant that all hospitals meeting
the inclusion criteria were invited to participate. In the
remaining countries, hospitals were randomly sampled from a
list of hospitals that met the sampling criteria. Hospital
recruitment was done by the country coordinators, who used
different strategies. To make participation more appealing to
hospitals, a package of advantages was offered to the hospitals,
including membership in the MARQuIS network, a certificate
of participation, and free subscription to the project’s news-
letter. Hospitals that agreed to participate in the survey received
an e-mail inviting them to enter the MARQuIS website (http://
www.marquis.be) and fill out the web-based questionnaire.
Upon request, a paper version of the questionnaire could be
used and sent to the researchers (MJMHL or IR). Data were
collected from the beginning of April to the end of August 2006.
Hospitals received up to three reminders. Again, country
coordinators used different approaches to raise the response
rates.
Validation of the data
To validate the questionnaire data, two analyses were
performed by using data collected during on-site hospital visits
in a selected sample of 89 hospitals that had previously
completed the questionnaire. Visits were performed by inde-
pendent external auditors. All aspects of on-site visits are
described in detail elsewhere.
32
During the visits, the hospitals’ key informants were asked to
answer 25 questions that had been previously asked in the
questionnaire. The reliability of the questionnaire was assessed
by the level of agreement between the responses to these 25
questions as given in the questionnaire and during the on-site
visits. In addition, for 14 of these 25 questions the external
auditors requested evidence to check the answers given during
the audit. Criterion validity was then assessed as the degree of
agreement between the information provided by key infor-
mants and the evidence found to underpin this information.
Reliability and validity were assessed as the index of expected
agreement, which is the proportion of cases in which the results
of both assessments matched.
33
RESULTS
Response rates and study population
The country coordinators approached a total of 1396 hospitals,
of which 483 visited the web-based questionnaire and ulti-
mately 389 submitted the completed questionnaire (table 1).
Response rates varied per country. The study population
consisted of public (80%) as well as private (20%) hospitals,
and included university (23.5%), teaching (48.9%) and non-
teaching hospitals (27.6%). The mean number of sites per
hospital was 2.46. Almost a quarter of all hospitals were
considering collaboration to deliver cross-border patient care,
but few hospitals were doing so at the time of the study.
15
Figure 1 Structure of the MARQuIS questionnaire. AMI, acute
myocardial infarction; QI, quality improvement.
Table 1 Hospital recruitment and response rates by country
Hospitals
approached
Hospitals entering
web-based
questionnaire
Hospitals
concluding web-
based
questionnaire
UK 250 41 14
Ireland 44 29 25
The Netherlands 97 12 10
Belgium 45 33 25
France 322 100 78
Spain 307 131 113
Poland 250 84 80
Czech Republic 81 53 44
Total 1396 483 389
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Regarding reliability, comparison of the information obtained
for 25 items from questionnaires and on-site visits resulted in
the following ranges of agreement: for five items agreement was
over 90%, for 12 items the level of agreement was .70% and
,90%, and for eight items agreement was ,70%. Given the
period of 7–9 months between the questionnaire and the on-site
visits, it is likely that at least some of the items studied had
actually changed. In addition, the 14 items analysed to assess
criterion validity resulted in the following levels of agreement:
seven items had an agreement index of .90%, six items rated
.70% and ,90%, and one item scored an index of ,70%. Based
on these results, we considered the information collected with
the questionnaire a fair approximation of the actual situation at
participating hospitals.
QI strategies
A previous MARQuIS study
34 identified seven mandatory QI
strategies for hospitals. The extent to which these strategies are
applied at European hospitals is reported below.
QI strategy 1: Organisational quality management programmes
Hospitals reported using quality management programmes in
developing and implementing QI (table 2). Overall, the
International Organization for Standardization (ISO) 9000
management system standards were used most often, and the
European Foundation for Quality Management (EFQM) model
was used least often. However, there were wide variations
between countries. Belgium was the only country where the
EFQM model was preferred by most hospitals (60.9%); in all
other countries the ISO system was the dominant scheme. In
Poland (50.0%), the Czech Republic (59.5%), and Spain (70.3%)
the use of ISO was widespread. In Spain some hospitals seemed
to use both schemes. Irish hospitals reported moderate use of a
quality management programme (ISO=31.6%, EFQM 20.0%),
but stressed the systematic use of specific QI teams in most of
their hospital departments, either systematically (47.8%) or
unsystematically (17.4%). French hospitals relied least on the
programmatic approach with the ISO (28.6%) or EFQM system
(3.4%), and the availability if QI teams was limited (27.7%).
Responsibilities for, and policies on, blood transfusion, the
use of antibiotics, and hospital infection control were clearly
assigned to a committee or person in almost all hospitals across
Europe, with the exception of Czech hospitals, which reported
significantly less clear organisation for all three hospital-wide
functions. Spanish hospitals showed a gap in organising
responsibilities for blood transfusion (87.5%), and Irish hospitals
in the use of antibiotics (87%). Responsibility for the prevention
of bed sores seemed less structured within European hospitals,
varying from a reported 66.7% in Ireland to 95.8% in Belgium.
QI strategy 2: Systems for obtaining patients’ views
Monitoring the views of patients by systematically conducting
patient surveys was a common practice in 64.5% of the
participating European hospitals. The Czech Republic stood
out, reporting that 91.9% of their hospitals systematically
monitored patient views. These numbers refer to hospital-wide
systems for collecting patients’ views on the care they received.
At the department level, patients are asked at discharge for their
opinion on the quality of care delivered by the hospital staff. In
France this strategy was widely implemented, with approxi-
mately 65% of the hospitals reporting a policy to measure
patients’ opinion at discharge. In Poland, this was a common
practice in less than 14% of the hospitals. The rates varied
significantly for the three medical conditions included in our
study, and variation between countries seemed greater than
within countries (table 3).
Across participating European hospitals, patient involvement
seemed to be little developed. Hospitals were asked to identify
the activities in which individual patients or patient organisa-
tions were always or almost always involved. Participation in
the design of protocols or the development of standards was
reported by 3% to 4% of all hospitals; participation in
improvement projects or in quality committees was reported
by less than 10%. Patient involvement was best implemented in
France, with almost 40% of the hospitals reporting that they
Table 2 Quality improvement (QI) strategies as applied in European hospitals: organisational quality
management programmes/activities; total and per country*, numbers are positive responses in valid
percentages (total item response in absolute numbers)
Specification of QI strategy Total Ireland Belgium France Spain Poland
Czech
Republic
The use of ISO in implementing a
quality system
51.2 (336) 31.6 (19) 21.7 (23) 28.6 (63) 70.3 (101) 50.0 (76) 59.5 (37)
The use of EFQM in implementing a
quality system
29.5 (319) 20.0 (20) 60.9 (23) 3.4 (59) 57.4 (101) 4.3 (69) 20.0 (30)
Active quality improvement team(s)/
circles{
349 23 24 65 106 76 37
1 27.5 47.8 4.2 7.7 19.8 42.1 48.6
2 17.5 17.4 41.7 20.0 16.0 14.5 13.5
3 38.1 30.4 29.2 47.7 53.8 23.7 13.5
4 13.2 4.3 25.0 23.1 8.5 9.2 21.6
Committee or person responsible for:
Hospital infections control 98.9 (353) 100 (25) 100 (24) 100 (78) 100 (107) 100 (80) 89.5 (38)
Blood transfusion 92.2 (348) 100 (25) 100 (24) 100 (78) 87.5 (104) 92.1 (76) 78.9 (38)
Prevention of bed sores 85.3 (346) 66.7 (21) 95.8 (24) 79.7 (64) 94.2 (104) 78.9 (76) 84.6 (39)
Policy on use of antibiotics 92.6 (352) 87.0 (23) 95.8 (24) 96.9 (65) 98.1 (106) 96.1 (76) 66.7 (39)
*The results for the UK and the Netherlands are included in the total scores but not listed separately, due to the very low response
rates.
{The sum of percentages may not always equal 100%; the percentage answers ‘‘don’t know/no answer’’ are not listed here. 1=
yes, in most departments (.50%); 2= yes, in most departments (.50%), but not systematically; 3= yes, in some departments
(,50%); 4= no.
EFQM, European Foundation for Quality Management.
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numbers are valid percentages{)
Specification of QI strategy Total Ireland Belgium France Spain Poland
Czech
Republic
Monitoring the views of patients/performing patient surveys (n=344) 344 22 23 66 104 75 37
1 64.5 54.5 60.9 56.1 67.3 61.3 91.9
2 14 18.2 13.0 13.6 11.5 14.7 8.1
3 15.7 27.3 13.0 21.2 16.3 16.0 0
4 4.7 0 8.7 7.6 4.8 5.3 0
Analysis of patient complaints (n=350) 350 23 24 66 106 73 38
1 85.7 82.6 83.3 83.3 88.7 84.0 92.1
2 6.6 4.3 8.3 6.1 2.8 8.0 7.9
3 5.4 8.7 4.2 9.1 5.7 5.3 0
4 1.7 4.3 4.2 1.5 2.8 0 0
Patient involvement in{:
Discussing the results of patient surveys and complaints handling (n=345) 345 23 24 63 105 75 38
1 7.2 4.3 0 20.6 1.9 4.0 7.9
2 6.7 4.3 8.3 19.0 1.0 4.0 2.6
3 19.1 30.4 12.5 30.2 17.1 9.3 15.8
4 60.6 52.2 70.8 22.2 74.3 76.0 68.4
The development of quality criteria/standards (n=348) 348 23 24 65 106 75 38
1 1.7 0 0 1.5 0 1.3 7.9
2 2.3 8.7 0 2.3 0 4.0 0
3 16.1 34.8 16.7 16.9 7.5 9.3 10.5
4 73.6 52.2 70.8 72.3 86.8 77.3 76.3
Designing protocols (n=345) 345 22 24 65 104 75 38
1 1.2 0 0 0 0 2.7 5.3
2 1.7 4.5 0 3.1 0 2.7 0
3 15.1 27.3 8.3 24.6 8.7 6.7 0
4 76.5 63.6 83.3 70.8 86.5 77.3 89.5
The evaluation of achieving quality objectives (n=347) 347 23 24 66 104 75 38
1 4.9 0 8.3 6.1 1.0 8.0 5.3
2 7.2 13.0 8.3 9.1 1.9 10.7 2.6
3 20.5 56.5 16.7 40.9 8.7 8.0 7.9
4 61.4 26.1 58.3 42.4 82.7 61.3 78.9
Participation in (quality) committees (n=345) 345 23 24 66 104 73 37
1 7.0 8.7 0 25.8 1.0 1.4 2.7
2 2.6 8.7 0 6.1 0 0 2.7
3 18.6 30.4 12.5 47.0 12.5 2.7 0
4 65.5 43.5 79.2 21.2 80.8 82.2 89.2
Participation in improvement projects (n=342) 342 22 22 66 103 74 38
1 3.5 9.1 0 6.1 1.0 1.4 7.9
2 5.8 9.1 0 10.6 1.9 6.8 0
3 27.5 40.9 22.7 53.0 21.4 13.5 5.3
4 57.0 36.4 68.2 30.3 67.0 68.9 81.6
Patients’ opinion about quality of care asked at discharge
(for patients with acute myocardial infarction) (n=319)
319 22 24 49 102 69 37
1 34.5 22.7 37.5 69.4 39.2 8.7 40.5
2 15.4 13.6 12.5 12.2 12.7 15.9 27.0
3 23.8 18.2 37.5 8.2 22.5 24.6 29.7
4 20.7 31.8 8.3 6.1 22.5 43.5 2.7
Patients’ opinion about quality of care asked at discharge
(for patients with appendicitis) (n=313)
313 22 21 51 100 71 34
1 39.6 22.7 47.6 76.5 44.0 8.5 47.1
2 14.7 18.2 4.8 13.7 10.0 19.7 17.6
3 19.8 18.2 23.8 3.9 24.0 21.1 20.6
4 19.2 22.7 14.3 2.0 21.0 36.6 11.8
Patients’ opinion about quality of care asked at discharge
(patients at maternal service) (n=301)
301 18 24 50 87 73 34
1 44.9 27.8 41.7 50.0 44.8 24.7 50.0
2 14.6 11.1 16.7 11.8 14.9 20.5 11.8
3 14.0 11.1 16.7 23.5 14.9 15.1 23.5
4 15.3 22.2 20.8 2.9 17.2 24.7 2.9
*The results for the UK and the Netherlands are included in the total but not listed separately, due to the very low response rates. {The sum of percentages may not always equal
100%; the percentage answers ‘‘don’t know/no answer’’ are not listed here. 1= yes, in most departments (.50%); 2= yes, in most departments (.50%), but not systematically;
3= yes, in some departments (,50%); 4= no. {From this point on the answer categories 1–4 should be read as: 1= yes always; 2= most of the time; 3= sometimes; 4=
no.
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surveys or complaints, and 32% stating that patients partici-
pated in quality committees.
QI strategy 3: Patient safety systems
Hospitals were asked how patient safety was organised and
managed, whether the results were reported, and if so, how
they were reported (table 4). Responsibility for patient safety
was assigned to a committee or person in approximately 75% of
the hospitals. At 39.1% of the hospitals a risk management
programme or system was in place; 50% of the hospitals
systematically reported and analysed adverse events, and 55.6%
also reported complications to the medical staff. These are
average numbers for Europe; variation between countries was
substantial. Irish hospitals scored consistently high (.90%), and
Belgium and Spanish hospitals relatively low on the availability
of safety systems.
Specific safety questions addressed drug safety management
and patient identification. In general, drug safety seemed to be
assured in all participating hospitals: the use of drugs was
standardised and controlled, and systems for storing, checking
and preventing unauthorised access to drugs seemed well
implemented. Electronic drug prescriptions were used widely
only in Czech hospitals (86.8%). By comparison, in Ireland a
Table 5 Quality improvement (QI) strategies as applied in European hospitals: clinical and practice guidelines; total and per country*, numbers are
positive responses in valid percentages (total item response in absolute numbers)
Specification of QI strategy Total Ireland Belgium France Spain Poland Czech Republic
Hospital-wide guidelines:
Preoperative assessment 74.8 (306) 72.7 (22) 90.5 (21) 57.4 (47) 71.4 (98) 75.7 (70) 88.2 (34)
Use of antibiotics 83.0 (311) 63.6 (22) 100 (22) 88.2 (51) 82.5 (97) 92.9 (70) 51.4 (35)
Prophylactic use of antibiotics 89.6 (309) 66.7 (21) 100 (22) 94.1 (51) 94.8 (97) 91.4 (70) 71.4 (35)
Standard operating procedures for various types of
laboratories:
Clinical chemistry 93.5 (310) 95.5 (22) 100 (22) 88.5 (52) 94.7 (95) 93.8 (65) 89.5 (38)
Pathology 72.5 (265) 95.7 (23) 76.2 (21) 71.0 (31) 82.6 (92) 46.0 (50) 58.8 (34)
Microbiology laboratory 87.6 (298) 95.2 (21) 100 (22) 89.8 (49) 90.5 (95) 85.9 (64) 66.7 (33)
Pharmacy 86.9 (314) 91.3 (23) 86.4 (22) 90.2 (61) 92.7 (96) 87.7 (65) 59.4 (32)
Diagnostic radiology 89.0 (310) 86.4 (22) 100 (21) 83.9 (56) 92.6 (95) 89.7 (68) 79.4 (34)
Clinical guidelines for AMI: management of AMI patients 86.7 (316) 72.7 (22) 95.8 (24) 89.1 (46) 89.3 (103) 79.4 (68) 86.8 (38)
Clinical guidelines for appendicitis:
Management of suspected appendicitis 54.3 (311) 36.4 (22) 47.8 (23) 52.0 (50) 49.5 (97) 67.6 (71) 51.4 (35)
Wrong site, wrong surgery 42.0 (307) 68.2 (22) 54.5 (22) 47.9 (48) 15.6 (96) 57.7 (71) 29.4 (34)
Clinical guidelines for obstetrics:
Breech presentation 71.5 (281) 58.8 (17) 81.8 (22) 61.7 (47) 60.8 (79) 90.0 (70) 59.4 (32)
VBAC 64.5 (293) 35.3 (17) 52.0 (25) 64.6 (48) 59.0 (83) 83.3 (72) 50.0 (34)
*The results for the UK and the Netherlands are included in the total but not listed separately, due to the very low response rates.
AMI, acute myocardial infarction; VBAC, vaginal birth after caesarean section.
Table 6 Quality improvement (QI) strategies as applied in European hospitals: performance indicators or measures; total and per country*, numbers
are positive responses in valid percentages (total item response in absolute numbers)
Specification of QI strategy Total Ireland Belgium France Spain Poland Czech Republic
Availability of AMI performance indicators:
Door-to-needle time 57.7 (291) 68.2 (22) 62.5 (24) 45.2 (42) 62.0 (92) 51.6 (64) 55.9 (34)
Receipt of reperfusion 70.3 (293) 54.5 (22) 75.0 (24) 61.4 (44) 66.7 (93) 79.4 (63) 76.5 (34)
Aspirin use ,24 h 71.8 (291) 68.2 (22) 79.2 (24) 59.1 (44) 69.2 (91) 82.5 (63) 70.6 (34)
Prescription ACE inhibitors at discharge 67.5 (292) 63.6 (22) 73.9 (23) 53.5 (43) 59.1 (93) 84.4 (64) 67.6 (34)
Prescription of b-blockers at discharge 71.2 (288) 63.6 (22) 73.9 (23) 51.2 (43) 69.6 (92) 87.3 (63) 71.9 (32)
Prescription of aspirin at discharge 73.6 (288) 68.2 (22) 83.3 (24) 58.1 (43) 71.4 (91) 85.5 (62) 69.7 (33)
Inpatient mortality 74.4 (289) 57.1 (21) 79.2 (24) 54.8 (42) 87.0 (92) 77.4 (62) 70.6 (34)
Availability of performance indicators for the management of appendicitis:
Prophylactic antibiotics 53.8 (290) 33.3 (21) 43.5 (23) 43.2 (44) 65.2 (92) 73.5 (68) 13.3 (30)
Negative appendectomy 46.5 (288) 33.3 (21) 43.5 (23) 42.2 (45) 45.1 (91) 53.0 (66) 50.0 (30)
Rate of lap versus open appendectomy 51.0 (286) 47.6 (21) 60.9 (23) 62.2 (45) 58.7 (92) 21.5 (65) 64.3 (28)
Perforated appendicitis operated 24 h after admittance 42.0 (283) 20.0 (20) 39.1 (23) 29.5 (44) 40.7 (91) 50.8 (63) 56.7 (30)
Wound infections 68.2 (280) 50.0 (20) 47.8 (23) 47.7 (44) 77.8 (90) 75.4 (61) 80.0 (30)
Availability of performance indicators for deliveries:
Induced labour rate 67.5 (280) 58.8 (17) 75.0 (20) 61.7 (47) 60.5 (81) 76.8 (69) 62.5 (32)
% Caesarean sections of total deliveries 85.3 (278) 64.7 (17) 90.0 (20) 83.7 (49) 87.7 (81) 91.0 (67) 74.2 (31)
VBAC rate 54.0 (274) 35.3 (17) 50.0 (20) 44.7 (47) 55.8 (77) 67.6 (68) 51.6 (31)
Deliveries with peridural anaesthesia 71.9 (278) 52.9 (17) 85.0 (20) 83.3 (48) 81.3 (80) 58.8 (68) 54.8 (31)
*The results for the UK and the Netherlands are included in the total but not listed separately, due to the very low response rates.
AMI, acute myocardial infarction; VBAC, vaginal birth after caesarean section.
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tions. For patient identification systems the findings were the
opposite, with 100% of Irish versus 29.4% of Czech hospitals
using bracelets to identify admitted patients.
QI strategy 4: Clinical guidelines
Clinical guidelines were widely used at participating European
hospitals. Hospital-wide guidelines for preoperative assessment
and prophylactic antibiotic use were in place in the vast
majority (75–90%) of hospitals. In the Czech Republic and
Ireland, guidelines for prophylactic antibiotic use were least
widely used, versus 100% coverage in Belgian hospitals.
Laboratory work seemed to be highly standardised across the
various types of laboratories across Europe. On average,
standard operating procedures (SOPs) were available in approxi-
mately 90% of all hospitals. At the department level, availability
of clinical guidelines or protocols was significantly less common.
In summary, guidelines were available for the management of
patients with AMI (mean =86.7%), appendicitis (mean
=54.3%), or obstetrical problems such as breech presentation
(71.5%) and vaginal birth after caesarean delivery (64.5%).
Between-country variation for the availability of clinical or
practice guidelines was limited for hospital-wide guidelines and
SOPs, but substantial for condition-related, department-level
guidelines (table 5).
QI strategy 5: Performance indicators or measures
For the three medical conditions included in this study,
hospitals were asked to report the availability of performance
data for a selection of clinical indicators. Table 6 shows the
findings. In summary, the availability of AMI performance data
was most complete, averaging approximately 70% for the seven
selected indicators. Poland reported the highest percentages,
France the lowest. Performance data on the management of
appendicitis were being collected for approximately 50% of the
five indicators, varying from 42% for perforated appendicitis
treated surgically 24 h after admission to 68.2% for wound
infections. The Czech Republic and Poland performed best in
this area. Lastly, the statistics for obstetrical indicators varied
from 54.0% for the rate of vaginal birth after caesarean delivery
to 85.3% for the percentage of caesarian deliveries. Obstetrical
data were most complete in Poland and Belgium, and least
complete in Ireland (table 6).
QI strategy 6: Internal audit, assessment of clinical standards
Medical staff performance was systematically reviewed at 50%
of the participating hospitals, and peer review (site visits) was
conducted at approximately 25%. Between-country variations
were considerable. Belgium, Poland and the Czech Republic
reported that over 60% of the hospitals performed medical staff
performance reviews, versus 26.1% of Irish hospitals. However,
Irish hospitals made more use of peer review (site visits) than
any other European country (39.1%).
On average, 50% of the laboratories at European hospitals
were periodically surveyed by an internal audit team.
Percentages varied according to the type of laboratory and
between countries. France reported generally low rates; in
Poland internal auditing seemed broadly implemented.
However, only a third of the Polish hospitals reported the
results of internal audits to their governing boards, versus
approximately 90% of the hospitals in the Czech Republic and
Ireland. Polish hospitals more openly shared the results with
their medical staffs (59.2%), but other countries reported higher
percentages. Belgium was the exception here: only 40%
disclosed their results to medical staff (table 7).
QI strategy 7: External assessment
Most hospitals (88%) have been assessed (at least in part) by an
external organisation such as an accreditation (59.4%) or
certification (49.4%) institute, a patient organisation (18.5%),
or a government inspection body (66%). Some hospitals were
audited by more than one organisation. In Spain, for instance,
64.8% of all hospitals (n=88) reported being evaluated by an
accreditation body, and 63.6% by a certification institute. In
France (n=63), 93.7% of all hospitals had been accredited, and
in Ireland (n=22) 90.9%. In Poland (n=75), government
inspections were the most frequently reported type of external
evaluation (76%).
French hospitals reported being most open (92.3%), and
Spanish hospitals the least open (19.8%) about their assessment
results. On average, 52.9% of the hospitals in our sample
publicly disclosed their assessment results (table 8). Most
participating hospitals (84.3%) reported plans for re-evaluation
within the next 3 years (not shown). Accreditation bodies were
listed most frequently as the future assessors; in the Czech
Republic, Ireland, the UK, and the Netherlands, more than 85%
of the hospitals expressed this intention, and the figures were
78.1% for France and 77.3% for Spain.
Table 8 Quality improvement (QI) strategies as applied in European hospitals: external assessment, schemes and programmes; total and per
country*, numbers are positive responses in valid percentages (total item response in absolute numbers)
Specification of QI strategy Total Ireland Belgium France Spain Poland Czech Republic
(Part of) hospital previously externally assessed 88.0 (351) 100 (23) 95.8 (24) 96.9 (65) 85.8 (106) 82.9 (76) 71.8 (39)
External assessment by:
Accreditation institute 59.4 (323) 90.9 (22) 20.8 (24) 93.7 (63) 64.8 (88) 35.5 (76) 29.4 (34)
Certification institute 49.4 (314) 60.0 (20) 41.7 (24) 23.3 (60) 63.6 (88) 48.6 (72) 48.6 (37)
Patient/consumer organisation 18.5 (297) 33.3 (18) 34.8 (23) 3.4 (58) 5.3 (76) 18.9 (74) 36.4 (33)
Inspection 66.0 (318) 80.0 (20) 83.3 (24) 55.9 (59) 65.9 (91) 76.0 (75) 28.1 (32)
Public disclosure of assessment results 52.9 (331) 60.9 (23) 33.3 (24) 92.3 (65) 19.8 (91) 50.6 (77) 67.6 (34)
Previous external assessment of laboratories:
Clinical chemistry laboratory 68.6 (303) 57.1 (21) 76.2 (21) 65.2 (46) 59.4 (96) 70.8 (65) 81.6 (38)
Pathology laboratory 38.7 (261) 60.9 (23) 19.0 (21) 50.0 (28) 34.8 (92) 28.6 (49) 35.3 (34)
Microbiology laboratory 58.7 (283) 65.0 (20) 71.4 (21) 60.5 (43) 48.4 (93) 68.3 (60) 50.0 (32)
Pharmacy laboratory 54.6 (302) 72.7 (22) 59.1 (22) 65.5 (58) 39.6 (91) 62.9 (62) 39.4 (33)
Diagnostic radiology laboratory 56.8 (294) 85.0 (20) 60.0 (20) 61.2 (49) 47.3 (93) 56.5 (62) 60.0 (35)
*The results for the UK and the Netherlands are included in the total but not listed separately, due to the very low response rates.
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This study has some limitations. The response rates varied per
country, and were particularly low in the UK and the
Netherlands. This may be explained by the various approaches
used to recruit hospitals for the MARQuIS project, and to the
effect of questionnaire fatigue due to the over-application of
questionnaire surveys to evaluate healthcare performance in
general. We therefore cannot rule out participation bias. Also,
accuracy of the information is always a limitation when using
self-reported data. However, the results of our validation
process strongly suggest that the reported results are fairly
accurate. Further, translation of the questionnaire, the use of
jargon, and the involvement of people from various healthcare
systems may have caused differences in how the items were
interpreted. Lastly, hospitals may use local QI approaches or
tools not included in this questionnaire, in which case the
application of QI strategies, as described in this article, may
misrepresent the ‘‘maturity’’ of hospitals’ quality management
systems. These limitations should be taken into account when
interpreting results.
International comparisons can promote learning and the
spread of good practice, and are one of the ways in which the
European Community is expected to raise healthcare quality.
This study of how European hospitals apply seven common QI
strategies found considerable variation between the level of
implementation of the different strategies—a finding that leaves
considerable scope for progress in making QI a reality.
The use of QI strategies at the European level was determined
or at least influenced by national and international policy
making and regulation, as well as by national and local bottom-
up actions initiated by professionals or others.
35 In our study
88% of all hospitals reported having been externally assessed;
the widespread application of the ‘‘external assessment’’ QI
strategy can be ascribed to the fact that most countries have
adopted one or more models of external assessment (ie,
accreditation, certification or licensure) to ensure and improve
hospital performance, which in turn has been related to
financing healthcare delivery.
However, policies and regulations may not always be
effective, as shown by the fact that in most hospitals (.90%),
patient involvement in QI activities was lacking. This was
despite the various legal and other efforts undertaken by the
European Commission over the past decades to increase
citizens’ participation in QI, and in the organisation and
structure of health services in general.
45Future research should
focus on detecting barriers to the implementation of these QI
strategies. In this regard, efforts by the EU to facilitate
improvements and foster European collaboration may help to
further increase implementation.
36 37
Legislation recently proposed by the European Commission
stresses the values and principles of safe, high-quality health
services that underpin European health systems. However, the
question arises as to how these agreed-upon values and
principles can be applied by member states.
36 We believe our
results may help national policy makers to monitor the
attainment of healthcare policy goals. The application of more
QI strategies, however, may not necessarily imply more positive
effects on performance. Our findings would be even more
valuable if the demonstrated use of QI strategies could be
related to actual performance in hospitals. This would give EU
policy makers direct input for monitoring the development of
healthcare policies and regulations. Elsewhere in this supple-
ment this relationship is explored in greater depth.
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